Atopic Eczema/Dermatitis and AllergySkin penetration – in vivo measurementsNew born babiesTEWL on FaceScalp, nasolabial, lipTOWLSkin StrippingIn vitro – Franz cellIn vitro experimentation on porcine skinCultured cellsSkin ExplantsSweat Gland ActivityMiceSnakesCaninePigsLizardsToadsVarious

Atopic Eczema/Dermatitis and Allergy

Association between skin barrier development and early-onset atopic dermatitis: A longitudinal birth cohort study

J. Chittock, L. Kay, K. Brown, A. Cooke, T. Lavender, M. J. Cork, S. G. Danby, J Allergy Clin Immunol Volume 153, 2024, Number 3

Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition

J. Rousel, A. Nădăban, M. Saghari, L. Pagan, A. Zhuparris, B. Theelen, T. Gambrah, H. E. C. van der Wall. R. J. Vreeken, G. L. Feiss, T. Niemeyer-van der Kolk, J. Burggraaf, M. B. A. van Doorn, J. A. Bouwstra, R. Rissmann, Experimental Dermatology, 2023;00:1–12

Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab

E. Goleva, E. Berdyshev, S. Kreimer, J. A. Reisz, A. D’Alessandro, I. Bronova, T. Lyubchenko, B. N. Richers, C. F. Hall, O. Xiao, Anna-Sofia Bronoff, S. Bafna, I. Agueusop, E. Gloaguen, J. Zahn, R. Bissonnette, A. Zhang, and D. Y. M. Leung, J Allergy Clin Immunol Volume 155, 2025, Number 5

Dupilumab treatment restores epithelial barrier in nonlesional and lesional skin in children with atopic dermatitis,

M. J. Cork, et. al, Annals of Allergy, Asthma & Immunology, Available online 27 January 2026, In Press, Corrected Proof

TEWL on Face

In Vivo Assessment of Water Content, Trans-Epidermial Water Loss and Thickness in Human Facial Skin
E. Chirikhina, A. Chirikhin , P. Xiao, S. Dewsbury-Ennis 1 and F. Bianconi
Appl. Sci., 10(17), 6139, 2020
In vivo barrier challenge and long-term recovery in human facial skin
M. Gorcea, J. Hadgraft, M. E. Lane, D. J. Moore
International Journal of Cosmetic Science, 41, 250-256, 2012
Noninvasive Skin Barrier Assessment: Multiparametric Approach and Pilot Study
J. G. M. Logger, J. I. Olydam, W. Woliner-van der Weg, P. E. J. van Erp
Cosmetics, 6(1), 20, 2019
A proof-of-principle study comparing barrier function and cell morphology in face and body skin
M. Gorcea, M. E. Lane and D. J. Moore
International Journal of Cosmetic Science, 41, 613–616, 2019
Facial Skin Pigmentation is not related to Stratum Corneum Cohesion, Basal Transepidermal Water Loss, Barrier Integrity and Barrier Repair
R. Voegeli, A.V. Rawlings & B. Summers
IJCS, 37(2), 241-52, 2015
In-vivo Barrier Challenge and Initial Recovery in Human Facial Skin
M. Gorcea, J. Hadgraft, D.J. Moore & M.E. Lane
Skin Res Tech, 19(1), e375–e382, 2013
In vivo barrier challenge and long-term recovery in human facial skin
M. Gorcea, J. Hadgraft, M. E. Lane, D. J. Moore
International Journal of Cosmetic Science, 41, 250-256, 2012
Assessment of cumulative exposure to UVA through the study of asymmetrical facial skin aging
S. Mac-Mary, J.-M. Sainthillier, A. Jeudy, C. Sladen, C. Williams, M. Bell, P. Humbert
Clinical Interventions in Aging, 5, 277–284, 2010
Increased Basal Transepidermal Water Loss leads to Elevation of some but not all Stratum Corneum Serine Proteases
R. Vögeli, A.V. Rawlings, S. Doppler & T. Schreier Int J Cosmet Sci, 30, 435-442, 2008
Profiling of Serine Protease Activities in Human Stratum Corneum and Detection of a Stratum Corneum Tryptase-like Enzyme
R. Vögeli, A.V. Rawlings, S. Doppler, J. Heiland & T. Schreier Int J Cosmet Sci, 29(3), 191-200, 2007

TOWL

An investigation of how fungal infection influences drug penetration through onychomycosis patient’s nail plates
W.J. McAuley, S.A. Jonesb, M.J. Traynora, S. Guesnéa, S. Murdanc, M.B. Brown
European Journal of Pharmaceutics and Biopharmaceutics, 102, 178-184, May 2016
UV-curable gels as topical nail medicines: In vivo residence, anti-fungal efficacy and influence of gel components on their properties
L.V. Kerai, S. Hilton, M. Maugueret, B.B. Kazi, J. Faull, S. Bhakta, S. Murdan
International Journal of Pharmaceutics, 514(1):244-254, 2016